4//SEC Filing
Bizily Scott 4
Accession 0001193125-25-221028
CIK 0001650648other
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 9:50 PM ET
Size
5.0 KB
Accession
0001193125-25-221028
Insider Transaction Report
Form 4
Bizily Scott
Chief Legal Officer
Transactions
- Sale
Common Stock
2025-09-23$8.00/sh−2,407$19,256→ 7,596 total
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025.
- [F2]Reflects 3,222 shares of the Issuer's common stock purchased under the Issuer's Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3.
Documents
Issuer
4D Molecular Therapeutics, Inc.
CIK 0001650648
Entity typeother
Related Parties
1- filerCIK 0001920738
Filing Metadata
- Form type
- 4
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 9:50 PM ET
- Size
- 5.0 KB